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Letters to the
Editor
Systolic anterior motion of the
mitral valve
To the Editor:
We read with interest the article from
Brown and colleagues1 questioning the op-
timal management of systolic anterior mo-
tion (SAM) after mitral valve reconstruc-
tive surgery. In their series, SAM occurred
in 11% of patients with degenerative valve
disease who underwent mitral valve repair.
However, they also showed that, in the
majority of cases, this complication could
be treated conservatively and did not re-
quire a reoperation provided that beta
blockers were given over a certain period
of time. If we agree with them that a sur-
gical intervention is not always necessary,
we think that this article raises another im-
portant question: would it not have been
better to try to avoid SAM in these patients
and therefore avoid postoperative beta
blockers, certainly useful in this setting but
not without side effects?
The mechanism of SAM, the risk fac-
tors involved, and the technical means to
prevent it are now widely established.2,3
SAM occurs when there is a discrepancy
between the amount of valvular tissue and
the mitral valve orifice area. After valvular
reconstruction, the two major risk factors
predisposing to SAM are (1) excess leaflet
tissue (Barlow disease) and (2) implanta-
tion of a too small prosthetic ring or band.
Postoperative SAM can be prevented pro-
vided that the principal rules of reconstruc-
tive surgery are applied systematically and
include (1) reduction of the height of the
posterior leaflet to less than 15 mm when-
ever excess tissue is present, (2) proper
sizing of the anterior leaflet, and (3) inser-
tion of a large prosthetic ring.3
In Barlow disease, the insertion of rings
equal to or greater than 36 mm is usually
necessary.4 In this study, the authors found
no correlation between the size of the ring
and the occurrence of SAM; however, they
did not mention the different sizes of im-
planted rings. Four of the 7 patients who
underwent reoperation had a size 30- to
34-mm partial flexible band, which is con-
sidered very small in patients “at risk of
SAM.”1 In addition, among these 7 pa-
tients, the resolution of SAM required the
removal of the ring in 3 patients, demon-
strating the role played by the implantation
of a ring of inadequate size.
The authors did not provide information
on the different types of degenerative val-
vular diseases in their series, in particular
the respective number with Barlow dis-
eases and fibroelastic deficiency, a distinc-
tion made possible in most instances by
clinical and morphologic criteria.5 This
would have been important information in-
asmuch as a partial triangular resection of
the posterior leaflet is usually sufficient for
preventing SAM in fibroelastic deficiency
whereas a sliding leaflet technique reduc-
ing the height of the posterior leaflet is
necessary in Barlow. Because the latter
technique was used in only 1 case in the
authors’ series, one may postulate that the
11% incidence of SAM that they observed
involved Barlow valves and could have been
prevented by a sliding leaflet technique. We
are aware that some surgeons are reluctant to
use this technique, arguing that it is difficult
and that the leaflet tissue should be respected
rather than resected. However, resecting
pathologic tissue is current practice in sur-
gery whenever it creates deleterious effects.
In addition, the sliding leaflet technique is
actually not difficult3 and certainly is prefer-
able to beta blockers. After careful applica-
tion of the basic rules underlined above,
SAM has been practically eliminated in our
experience.3,4
One of the most remarkable values of
reconstructive valve surgery is to allow the
patient to enjoy a normal life without med-
ication and, in many instances, “to be cured
for the rest of his life.”5 We would like to
congratulate the authors for their seminal
contributions in this field and their excel-
lent results.
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Reply to the Editor:
We are pleased that Drs Filsoufi and Car-
pentier enjoyed our article, but they may
have misinterpreted our results. We are
not aware of other studies of systolic
anterior motion (SAM) that include early
and late intraoperative echocardiography.
Our study also differs from others in that
we have included only patients with mi-
tral valve pathologies at risk of SAM
development. Some authors do not make
this distinction and report an artificially
low incidence.1 The 11% incidence of
SAM, which Drs Filsoufi and Carpentier
mention, includes all patients with SAM
on early intraoperative transesophageal
echocardiography. After medical man-
agement, the incidence of SAM intraop-
eratively decreases to 6% and then to 4%
by hospital dismissal. Previous investiga-
tions that estimate the risk of SAM have
reported echocardiographic findings at
varying times, and therefore comparisons
are difficult.1-3 But the important point is
that the risk of SAM appears low and
diminishes with time and ventricular re-
modeling.
Therefore the question of whether pro-
phylactic measures should be used to “pre-
vent SAM” is a bit more complicated than
the correspondents might be thinking. As
noted in the article, the risk of development
of symptoms related to late SAM using the
techniques we describe is extremely low
(16/17 patients in New York Heart Asso-
ciation class I, 1 patient lost to follow-up).
Also, SAM has been described with all
methods of valve repair, including qua-
drangular resection with a sliding leaflet
technique.4-7
Morgan Brown, MD
Hartzell Schaff, MD
Division of Cardiovascular Surgery
Mayo Clinic, USA
Rochester, Minn
E-mail: schaff@mayo.edu
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Tricuspid valve repair: Indication
and type of repair
To the Editor:
We read with great interest the article by
Ghanta and colleagues1 concerning their re-
sults with repair of functional tricuspid regur-
gitation. After the comparison between Kay’s
annuloplasty versus ring annuloplasty on the
tricuspid valve, they concluded that there is
not a significant difference in the midterm
results. Ghanta and colleagues recommend
bicuspidization annuloplasty as an option to
ring annuloplasty because it is inexpensive,
simple, and reliable.
We do agree with the authors that
moderate-to-severe tricuspid regurgitation
should be repaired when a concomitant car-
diac procedure is performed. At our insti-
tution, we are rather liberal in the indica-
tion for tricuspid repair. We perform about
50 cases of repair yearly on the tricuspid
valve (46–61 per year in the last 3 years)
of approximately 1200 total cardiac proce-
dures. Our experiences show that repair of
tricuspid regurgitation improves early post-
operative outcome and long-term quality of
life. Long-term survival after cardiac sur-
gery depends mainly on the postoperative
left ventricular performance. Indications
for tricuspid valve repair should be decided
preoperatively, according to the results of
echocardiography. Intraoperative evalua-
tion of tricuspid regurgitation is not reliable
enough.
The method of repair on the tricuspid
valve is another question. Cohn2 recom-
mends use of a ring if the tricuspid regur-
gitation is severe and suture annuloplasty if
it is moderate. We have had good experi-
ences with both de Vega annuloplasty and
Kay’s suture bicuspidization. In our expe-
rience (published in 1980), we found that,
in about 70% of the cases, tricuspid repair
(de Vega or Kay’s) provided good results
at a mean follow-up of 4 years.3 Since then,
we used mostly de Vega repair with mul-
tifilament suture material, and we have had
good experiences in several hundred cases.
We even used an adjustable half-moon ring
for tricuspid annuloplasty in a group of
patients with good results.4 The ring annu-
loplasty had no better results compared
with those of the suture annuloplasty, it is
more expensive, and it takes more time and
can reduce annular flexibility. That is why
we do not use it routinely.
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